Neoepitopes generated by amino acid variants specifically found in pathogens or cancer cells are gaining momentum in immunotherapy development. HABIT (HLA Binding InTelligence) is a web platform designed to generate and analyse machine learning-based T cell epitope predictions for improved neoepitope discovery.
Introduction
Immune responses mediated by T cells are triggered by specific peptides (T cell epitopes) bound to the highly diverse human leukocyte antigens (HLA) (Blum et al., 2013) .
Variations in one single amino acid might impact peptide-HLA interactions and subsequent T cell responses (Unanue et al., 2016; Hilf et al., 2018) . Many computational methods have been developed for predicting peptide-HLA binding improving the efficiency of T cell epitope identification (Zhang et al., 2011) . However, using this type of tools to identify neoepitopes, such as the ones generated by cancer or pathogen-specific amino acid mutations, is not trivial. It requires individual prediction of wild-type and mutant sequences in each tool, the selection of all overlapping peptides including the amino acid positions of interest and the comparison of the results generated separately.
Thus, programming skills are needed to extract meaningful conclusions from the large outputs of HLA-peptide binding prediction data. Furthermore, data visualization and prioritization strategies, such as statistical tests or human population coverage calculation are inexistent in an integrated manner and would be of great value for immune-based therapy and diagnostic strategies (Oyarzun et al., 2015) . Taking this into account, we developed HABIT, which automates HLA binding prediction and provides advanced interpretation of the impact of amino acid variants in peptide-HLA binding (class I and II). It features an intuitive, user-friendly and interactive graphical interface that plots, summarizes and performs statistical comparisons on the antigenicity scores of wild-type and mutant epitope candidates.
Implementation
HABIT was developed in the RStudio v3.5.0, using the shiny v. 1.2.0 package (Chang et al., 2018) to create the web-based application. Plotly v.4.8.0 (Sievert, 2018) and DataTables v.0.4 (Xiu et al., 2018) packages were used for the generation of interactive plots and customizable tables. Peptide-HLA binding predictions tools (O'Donnell et al., 2018; Zhang et al., 2012) for HLA molecules were implemented in the back-end of HABIT to predict the peptide fragments with high binding affinity to HLA class I and class II molecules. All 8 to 14-mer peptides for wild-type and mutant sequences overlapping the position of the mutation of interest can be predicted to a set of class I alleles. Simultaneously, the binding affinity of 9-30 mer of peptides to HLA class II alleles can be predicted. Predicted antigenic scores are plotted and summarized enabling efficient selection of neoepitope candidates.
Results
To illustrate the relevance of the features implemented in HABIT, we analysed the effect of a somatic mutation (TP53 R248W) found in several types of human cancer (Tate et al., 2018) . Simultaneous HLA-binding prediction was launched for all wild-type and mutant peptides containing the amino acid residue of interest ( Figure 1A and B ). An interactive visual representation of the impact the R248W mutation had on HLA binding affinity was obtained. As shown in Figure 1C , the mutant amino acid generated several novel peptides predicted to bind strongly (in orange) to specific HLA class II proteins ( Figure 1C ).
Interactive tables detailing the differences between wild-type and mutant peptides were also generated ( Figure 1D ), including percentage of strong binders, mean HLA affinity and mean percentile rank, along with statistical analysis. Sort and search functionality highlighted the HLA proteins with higher affinity for the majority of the neoepitopes ( Figure 1D ). Information about HLA distribution across the globe, as a way to evaluate the impact of neoepitopes in the immune responses across distinct human populations was also obtained ( Figure 1E ).
Overall, HABIT provides a fast and user-friendly way to study neoepitopes, answering 
